Thursday
August 7, 2025
4:05 PM ET
AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms
Monday
July 7, 2025
4:05 PM ET
AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025
Thursday
May 8, 2025
4:05 PM ET
AbCellera Reports Q1 2025 Business Results
Thursday
April 3, 2025
4:05 PM ET
AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025
Thursday
February 27, 2025
4:05 PM ET
AbCellera Reports Full Year 2024 Business Results